Murcko scaffold
Ring system with 7 rings and 42 atoms
50 chemicals on CompoundList share this ring system.
- Rings
- 7
- Scaffold atoms
- 42
- Chemicals
- 50
- With full pages
- 9
Scaffold SMILES
O=C1CCC(OC2CCC(OC3CCC(OC4CCCc5cc6c(cc54)C(=O)c4ccccc4C6=O)OC3)OC2)OC1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 48 of 50 chemicals
Cinerubine A
CAS 34044-10-5C42H53NO16
Betaclamycin A
CAS 76264-95-4C40H51NO15
Antibiotic MA 144L1
CAS 64431-58-9C41H51NO15
Antibiotic MA 144G1
CAS 64520-15-6C42H53NO15
Antibiotic MA 144U5
CAS 65222-72-2C40H48O16
N-Didemethylaclacinomycin A
CAS 67508-84-3C40H49NO15
Aclarubicin hydrochloride
CAS 75443-99-1C42H54ClNO15
10-Decarbomethoxyaclacinomycin A
CAS 76264-91-0C40H51NO13
6-O-Methylaclacinomycin
CAS 76264-92-1C43H55NO15
Epelmycin E
CAS 138636-10-9C42H53NO16
epsilon-ISORMN-A
CAS 76264-94-3C42H53NO17
4''-Dehydrorhodomycin-Y
CAS 76264-96-5C40H51NO14
4-O-Methylaclacinomycin
CAS 76304-86-4C43H55NO15
10-Epi-aclacinomycin A
CAS 77448-81-8C42H53NO15
Sulfurmycin A
CAS 78173-90-7C43H53NO16
13-Methylaclacinomycin A
CAS 78776-19-9C43H55NO15
beta-Isorhodomycinone
CAS 80930-57-0C40H51NO16
alpha2-Rmn-A
CAS 80930-58-1C40H51NO15
Daunomycinone-A
CAS 80930-60-5C41H51NO15
Daunomycinone-L
CAS 80930-62-7C40H49NO15
Daunomycinone-K
CAS 80930-63-8C39H47NO15
RefChem:232135
CAS 79127-36-9C42H53NO16
Spartanamicin B
CAS 134910-04-6C42H53NO16
CG 11
CAS 86944-87-8C40H51NO15
- 1-Hydroxyauramycin A79217-17-7C41H51NO16
- 1-Hydroxysulfurmycin A79234-80-3C43H53NO17
- Cinerubin X104700-84-7C40H48O16
- Aclucinomycin A79617-46-2C42H53NO15
- Cinerubin A hydrochlorideC42H53NO16
- 10 suppliersAclarubicin57576-44-0C42H53NO15
- RefChem:105590266808-28-4C42H53NO16
- epsilon-Rhodomycin rdc76463-92-8C42H53NO15
- beta-Pyrromycin RDC77517-28-3C40H51NO15
- 1-Naphthacenecarboxylic acid, 1,2,3,4,6,11-hexahydro-4-((4-O-(3-O-acetyl-2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-6,11-dioxo-2-ethyl-2,5,7-trihydroxy-, methyl ester, (1R-(1-alpha,2-beta,4-beta))-, hydrate (2:1)81975-85-1C44H55NO16
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((4-O-(3-O-acetyl-2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-1-methoxy-6,8,11-trihydroxy-, (8S-cis)-, hydrate (2:3)81975-86-2C43H53NO16
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((4-O-(3-O-acetyl-2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-8-((acetyloxy)acetyl)-1-methoxy-6,8,11-trihydroxy-, (8S-cis)-81975-88-4C45H55NO18
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((4-O-(3-O-acetyl-2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-8-(hydroxyacetyl)-1-methoxy-6,8,11-trihydroxy-, (8S-cis)-81975-90-8C43H53NO17
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-6,8,11-trihydroxy-, (8S-cis)-81975-91-9C41H51NO16
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((4-O-(3-O-acetyl-2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-1,6,8,11-tetrahydroxy-, (8S-cis)-,hydrate81975-92-0C42H51NO16
- 2,4,3''-Tri-O-acetyl-2-hydroxyaclacinomycin A86651-71-0C48H59NO19
- 4,3''-Di-O-acetyl-2-hydroxyaclacinomycin A86651-72-1C46H57NO18
- 3''-O-Acetyl-2-hydroxyaclacinomycin86670-20-4C44H55NO17
- 4-Deoxyaclacinomycin A87080-93-1C42H53NO14
- Methyl (1R,2R,4S)-4-[(2R,4S,5R,6S)-4-(dimethylamino)-5-[(2S,4S,5R,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylateC42H53NO16
- Auramycin A78173-92-9C41H51NO15
- Trisarubicinol80470-08-2C40H51NO15
- Epelmycin A107807-25-0C42H53NO15
- Methyl (2R)-4-[4-(dimethylamino)-5-[4-hydroxy-6-methyl-5-(6-methyl-5-oxooxan-2-yl)oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylateC42H53NO16
Related scaffolds
Same ring framework with different atoms or bond orders
